SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001172661-21-000675
Filing Date
2021-02-16
Accepted
2021-02-16 14:41:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 firstmanhattan-vyne123120a2.htm SC 13G/A 55347
  Complete submission text file 0001172661-21-000675.txt   57078
Mailing Address 399 PARK AVE NEW YORK NY 10022
Business Address 399 PARK AVE NEW YORK NY 10022 2127563300
FIRST MANHATTAN CO (Filed by) CIK: 0000728083 (see all company filings)

IRS No.: 131957714 | State of Incorp.: NY | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Subject) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90268 | Film No.: 21636513
SIC: 2834 Pharmaceutical Preparations